drugset / Trial / NCT00019006
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Treatment
Summary
RATIONALE: Vaccines made from mutated ras peptides may make the body build an immune response to and kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of a vaccine containing mutated ras peptides and an immune adjuvant in treating patients who have colon, pancreatic, or lung cancer.
Timeline
- Start
- 1995-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ras peptide cancer vaccine | Vaccine | — | Subcutaneous |
| Background | Detox-B | Unknown | — | Subcutaneous |